Immunogenically, the difference in time response is strictly bound with the targeted interleukin pathway [1]: IL-23 primarily plays a pivotal role in orchestrating the inflammatory cascade by stimulating IL-17 production, contributing to the characteristic skin inflammation seen in psoriasis [2]. This evidence concerns the gene IL17A and psoriasis.